Current plan

Explorer

Upgrade

Payment details required

One or more limits reached

Daily profile views

0 / 3

Monthly profile views

0 / 15

Searches (last 30 days)

0 / 10

Add Entity

Startup Nation Finder

Current plan

Explorer

Pricing plans

Payment details required

Daily profile views

0 / 3

Monthly profile views

0 / 15

Searches (last 30 days)

0 / 10

Watchlist name*

Watchlist must have a valid name.

Description (optional)

0/300

Notifications Settings

Public content (accessible by all Finder users)

Add to List

Select notifications to recieve

Select all

Email Alerts

Receive notifications via email

Daily

Weekly

Monthly

Never

No Notifications are selected

Would you like to select any notifications?

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
#COMPANY_NAME#’s page on Startup Nation Finder

The invitation to claim the profile was originally sent to

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
#COMPANY_NAME#’s page on Startup Nation Finder

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Name*

Work Email* (please provide your email in the organization)

Position*

Notes

8 Characters, Uppercase letter (A-Z),
Lowercase letter (a-z), Digit (0-9)

Passwords do not match

I agree to receive Informational Emails from Startup Nation Finder as defined in the Privacy Policy and Terms of Use

Already have an account?

Or continue with

Last update Comments

Eric J. Messika, Ph.D, MBA

President & CEO at Coronis NeuroSciences Ltd.

About

During the past fifteen years, I have been extensively involved, independently and through Coronis Partners in the seeding and growth of emerging Biotech companies - from Private Equity Funding (more than $16M accumulated in eight companies), Strategy Building, Entrepreneur and Management Coaching, Business Development and Exit Strategy. Five out of the eight companies performed IPO's in TASE and the US, two of them yielded 5-10 fold return to investors. In the past two years, Coronis became a Specialty Pharma company, named Coronis Neurosciences (CNS) , developing peptide drugs for the treatment of neurocognitive and neurodegenerative disorders. CNS focuses on the treatment for a rare genetic autism named ADNP- Syndrome , encompassing global developmental delay and cognitive dysfunction in children. Our leading Drug (CP201) faces a Phase II/III pivotal clinical trials in ADNP children. Specialties: Investment Management, Entrepreneurship, Biotechnology Companies, Strategic Development,.

Career-Linked Companies in Finder

Coronis Neurosciences

Presumed Inactive

President & CEO

Startup Nation Finder

Create Watchlist

Add to List